|
|
|
| Efficacy of Magnesium Sulfate in Treating Elderly Patients with Cerebral Hemorrhage Complicated with Hypomagnesemia and its Effect on ET and NO Levels |
| LI Jujun, WANG Yonggang, JI Yuanchao, et al |
| Xunyang City Traditional Chinese Medicine Hospital,Ankang Shaanxi 725700 |
|
|
|
|
Abstract 【Objective】To investigate the efficacy of magnesium sulfate in treating elderly patients with cerebral hemorrhage complicated with hypomagnesemia and its effects on endothelin(ET) and nitric oxide(NO) levels. 【Methods】A total of 93 patients with cerebral hemorrhage complicated with hypomagnesemia admitted to our hospital were randomly divided into the observation group(n=47) and the control group(n=46). Both groups received conventional symptomatic treatments such as intracranial pressure reduction,hemostasis,and oxygen inhalation. The control group was intravenously dripped with Xingnaojing,while the observation group received magnesium sulfate treatment on top of the control group's treatment. The clinical efficacy,serum magnesium,ET,NO levels,and scores from the National Institutes of Health Stroke Scale(NIHSS) and activities of daily living(ADL) were compared before and after treatment. 【Results】The total effective rate of treatment in the observation group was higher than that in the control group(P<0.05). After treatment,the serum magnesium levels in both groups increased compared to before treatment,while ET and NO levels decreased(P<0.05). The observation group had higher post-treatment serum magnesium levels and lower post-treatment ET and NO levels than the control group(P<0.05). One and two weeks post-treatment,the ADL scores of both groups showed an upward trend,and the NIHSS scores showed a downward trend(P<0.05). Moreover,the post-treatment ADL score of the observation group was higher and the post-treatment NIHSS score was lower in the observation group than those in the control group(P<0.05). 【Conclusion】Magnesium sulfate has a good therapeutic effect on elderly patients with cerebral hemorrhage complicated with hypomagnesemia. It helps to increase serum magnesium,reduce NO and ET levels,promote the recovery of neurological function,and has significant application value.
|
|
Received: 31 August 2022
|
|
|
|
|
|
[1] KRENZLIN H,GRESSER E,JUSSEN D,et al. The cerebral thrombin system is activated after intracerebral hemorrhage and contributes to secondary lesion growth and poor neurological outcome in C57Bl/6 mice[J].J Neurotrauma,2020,37(12):1481-1490.
[2] QURESHI A I,FOSTER L D,LOBANOVA I,et al. Intensive blood pressure lowering in patients with moderate to severe grade acute cerebral hemorrhage:post hoc analysis of antihypertensive treatment of acute cerebral hemorrhage(ATACH)-2 trial[J].Cerebrovasc Dis,2020,49(3):244-252.
[3] 朱人定,丁新苑,王娟娟,等.低镁血症对老年脑出血患者的影响[J].中华老年医学杂志,2019,38(8):848-851.
[4] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2014)[J].中华神经科杂志,2015,48(6):435-444.
[5] 许光涛,赵宗茂,王淑霞,等.早期强化控压联合镇静镇痛策略对老年高血压脑出血患者血肿量及NIHSS的影响[J].河北医科大学学报,2018,39(7):782-786.
[6] 沈健,杨华.不同手术时机小骨窗显微手术治疗高血压脑出血与日常生活活动能力量表、格拉斯哥预后评分的相关性[J].中国老年学杂志,2017,37(2):354-355.
[7] MINHAS JS,PANERAI RB,SWIENTON D,et al. Feasibility of improving cerebral autoregulation in acute intracerebral hemorrhage(BREATHE-ICH) study:Results from an experimental interventional study[J].Int J Stroke,2020,15(6):627-637.
[8] TOBIESON L,ROSSITTI S,ZSIGMOND P,et al. Persistent metabolic disturbance in the perihemorrhagic zone despite a normalized cerebral blood flow following surgery for intracerebral hemorrhage[J].Neurosurgery,2019,84(6):1269-1279.
[9] 丁毅,韩和平,唐超.颅内压监测仪联合软通道穿刺引流术治疗高血压脑出血的疗效及对内皮素-1和基质金属蛋白酶-9的影响[J].中国医学装备,2022,19(1):107-111.
[10] 牛会坤,吴娜,王素影,等. 硫酸镁联合阿司匹林治疗妊娠期高血压疾病疗效及对超氧化物歧化酶、内皮素-1水平影响[J].中国计划生育学杂志,2021,29(2):284-287.
[11] 刘佳阳,吴秋莲,梁啦迪,等.依达拉奉联合尼莫地平对高血压脑出血患者脑血流、血清NO、MDA、HMGB1的影响[J].四川医学,2019,40(1):83-86.
[12] 马红梅,赵春水,郝彦超.脑出血患者血清一氧化氮、血管内皮生长因子及低氧诱导因子-1α水平与病理特征和预后的关系[J].广东医学,2019,40(24):3428-3432.
[13] 高继英,石代乐,高晓玲,等.活血涤痰汤联合高压氧对高血压脑出血神经功能恢复速度和血流动力学水平影响[J].中华中医药学刊,2020,38(9):213-216. |
|
|
|
2023, Vol. 40 
